Ownership history in CITIGROUP INC · 16 quarters on record
This page tracks every 13F SEC filing in which CITIGROUP INC reported a position in PROQR THRAPEUTICS N V (PRQR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 22,724 | +22,648 | +29800.0% | 0.00% | $48K | $2.13 |
| 2022 Q4 | REDUCED | 76 | -911 | -92.3% | 0.00% | $281 | $3.70 |
| 2022 Q3 | REDUCED | 987 | -276 | -21.9% | 0.00% | $1K | $0.74 |
| 2022 Q2 | REDUCED | 1,263 | -10,051 | -88.8% | 0.00% | $1K | $0.78 |
As of 2025 Q4 — sorted by position size